429
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Eye drops for dry eye disease during pregnancy and adverse neonatal outcomes: high-dimensional propensity score analyses

, , , ORCID Icon, , , & show all
Pages 384-393 | Received 11 Apr 2021, Accepted 17 Aug 2021, Published online: 29 Aug 2021

References

  • Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.008.
  • Schaumberg DA. Prevalence of dry eye disease among US men: estimates from the physicians’ health studies. Arch Ophthalmol. 2009;127(6):763–768. doi:10.1001/archophthalmol.2009.103.
  • Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136(2):318–326. doi:10.1016/S0002-9394(03)00218-6.
  • Vehof J, Kozareva D, Hysi PG, Hammond CJ. Prevalence and risk factors of dry eye disease in a British female cohort. Br J Ophthalmol. 2014;98(12):1712–1717. doi:10.1136/bjophthalmol-2014-305201.
  • McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology. 1998;105(6):1114–1119. doi:10.1016/S0161-6420(98)96016-X.
  • Uchino M, Nishiwaki Y, Michikawa T, et al. Prevalence and risk factors of dry eye disease in japan: koumi study. Ophthalmology. 2011;118(12):2361–2367. doi:10.1016/j.ophtha.2011.05.029.
  • Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W. Utility assessment among patients with dry eye disease. Ophthalmology. 2003;110(7):1412–1419. doi:10.1016/S0161-6420(03)00462-7.
  • Li M, Gong L, Sun X, Chapin WJ. Anxiety and depression in patients with dry eye syndrome. Curr Eye Res. 2011;36(1):1–7. doi:10.3109/02713683.2010.519850.
  • Akpek EK, Amescua G, Farid M, et al. Dry eye syndrome preferred practice pattern®. Ophthalmology. 2019;126(1):P286–P334. doi:10.1016/j.ophtha.2018.10.023.
  • Kojima T, Dogru M, Kawashima M, Nakamura S, Tsubota K. Advances in the diagnosis and treatment of dry eye. Prog Retin Eye Res. 2020 January;78:100842. doi:10.1016/j.preteyeres.2020.100842. Published online.
  • Medical WH. Treatment for dry eye in Japan. Investig Opthalmol Vis Sci. 2018;59(14):DES116–120. doi:10.1167/iovs.18-24130.
  • Son K-B. Trends in the utilization of sodium hyaluronate eye drops, including disposable and multiuse forms, in south korea: a 14-year longitudinal retrospective cohort study. Front Pharmacol. 2020;11:720. doi:10.3389/fphar.2020.00720.
  • Vaajanen A, Vapaatalo H, Single A. Drop in the eye – effects on the whole body? Open Ophthalmol J. 2017;11(1):305–314. doi:10.2174/1874364101711010305.
  • Kyorin Rimedio Co.,Ltd. Drug information sheet -hyaluronate na ophthalmic solution 0.1% “kyorin”-. Published 2019. Accessed February 18, 2021. http://www.rad-ar.or.jp/siori/englis h/kekka.cgi?n=41903
  • Santen Pharmaceutical Co.,Ltd. Drug information sheet -DIQUAS ophthalmic solution 3%-. Published 2015. Accessed June 3, 2020. http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=1898
  • Otsuka Pharmaceutical Co., Ltd. Drug information sheet -MUCOSTA ophthalmic suspension UD 2%-. Published 2015. Accessed June 3, 2020. http://www.rad-ar.or.jp/siori/english/kekka_plain.cgi?n=35738
  • Kimura S, Sato T, Ikeda S, Noda M, Nakayama T. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol. 2010;20(5):413–419. doi:10.2188/jea.JE20090066.
  • Nagai K, Tanaka T, Kodaira N, Kimura S, Takahashi Y, Nakayama T. Data resource profile: JMDC claims database sourced from health insurance societies. J Gen Fam Med. 2021;22(3):118–127. doi:10.1002/jgf2.422.
  • Spong CY. Defining “term” pregnancy: Recommendations from the defining “term” pregnancy workgroup. JAMA. 2013;309(23):2445–2446. doi:10.1001/jama.2013.6235.
  • Bérard A, Sheehy O, Zhao J-P, et al. Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case–control studies. Can Med Assoc J. 2019;191(7):E179–E187. doi:10.1503/cmaj.180963.
  • Sheehy O, Zhao J-P, Bérard A. Association between incident exposure to benzodiazepines in early pregnancy and risk of spontaneous abortion. JAMA Psychiatry. 2019;76(9):948–957. doi:10.1001/jamapsychiatry.2019.0963.
  • Bérard A, Sheehy O, Kurzinger M-L, Juhaeri J. Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes. J Allergy Clin Immunol. 2016;138(1):97–104.e7. doi:10.1016/j.jaci.2016.01.021.
  • Elliott B, Spence AR, Czuzoj-Shulman N, Abenhaim HA. Effect of Sjögren’s syndrome on maternal and neonatal outcomes of pregnancy. J Perinat Med. 2019;47(6):637–642. doi:10.1515/jpm-2019-0034.
  • Rom AL, Wu CS, Olsen J, et al. Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis: a nationwide cohort study. Arthritis Rheumatol. 2014;66(12):3265–3273. doi:10.1002/art.38874.
  • Mitchell K, Kaul M, Clowse M. The management of rheumatic diseases in pregnancy. Scand J Rheumatol. 2010;39(2):99–108. doi:10.3109/03009740903449313.
  • Hashimoto Y, Michihata N, Yamana H, et al. Ophthalmic corticosteroids in pregnant women with allergic conjunctivitis and adverse neonatal outcomes: propensity score analyses. Am J Ophthalmol. 2020;220:91–101. doi:10.1016/j.ajo.2020.07.011.
  • Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84. doi:10.1016/S0140-6736(08)60074-4.
  • Michihata N, Shigemi D, Sasabuchi Y, Matsui H, Jo T, Yasunaga H. Safety and effectiveness of Japanese herbal Kampo medicines for treatment of hyperemesis gravidarum. Int J Gynecol Obstet. 2019;145(2):182–186. doi:10.1002/ijgo.12781.
  • Moss SE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118(9):1264–1268. doi:10.1001/archopht.118.9.1264.
  • Liang Z, Yin M, Ma M, Wang Y, Kuang Y. Effect of maternal advanced endometriosis on risk of congenital malformations for infants born after in vitro fertilization and frozen–thawed embryo transfer: analysis of 28,600 newborns. Front Endocrinol. 2019;10:763. doi:10.3389/fendo.2019.00763.
  • Lee BK, Magnusson C, Gardner RM, et al. Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders. Brain Behav Immun. 2015;44:100–105. doi:10.1016/j.bbi.2014.09.001.
  • Sneider K, Christiansen OB, Sundtoft IB, Langhoff-Roos J. Recurrence of second trimester miscarriage and extreme preterm delivery at 16-27 weeks of gestation with a focus on cervical insufficiency and prophylactic cerclage. Acta Obstet Gynecol Scand. 2016;95(12):1383–1390. doi:10.1111/aogs.13027.
  • Cheung YB. A modified least-squares regression approach to the estimation of risk difference. Am J Epidemiol. 2007;166(11):1337–1344. doi:10.1093/aje/kwm223.
  • Spiegelman D. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162(3):199–200. doi:10.1093/aje/kwi188.
  • Ishimaru M. Introduction to high-dimensional propensity score analysis. Ann Clin Epidemiol. 2020;2(4):85–94. doi:10.37737/ace.2.4_85.
  • Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009;20(4):512–522. doi:10.1097/EDE.0b013e3181a663cc.
  • Huybrechts KF, Hernández-Díaz S, Straub L, et al. Association of maternal first-trimester ondansetron use with cardiac malformations and oral clefts in offspring. JAMA. 2018;320(23):2429. doi:10.1001/jama.2018.18307.
  • Yazdani C, McLaughlin T, Smeeding JE, Walt J. Prevalence of treated dry eye disease in a managed care population. Clin Ther. 2001;23(10):1672–1682. doi:10.1016/s0149-2918(01)80136-3.
  • Miljanović B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143(3):409–415.e2. doi:10.1016/j.ajo.2006.11.060.
  • Mertzanis P, Abetz L, Rajagopalan K, et al. The relative burden of dry eye in patients’ lives: Comparisons to a U.S. normative sample. Investig Opthalmol Vis Sci. 2005;46(1):46. doi:10.1167/iovs.03-0915.
  • Santen. Drug information sheet -hyaluronate ophthamic solution- [in Japanese]. Accessed March 11, 2021. https://www.info.pmda.go.jp/go/pack/1319720Q3078_1_15/
  • Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau Ministry of Health, Labour and Welfare. Report on the Deliberation Results. Published 2010. Accessed June 9, 2020. https://www.pmda.go.jp/files/000153954.pdf
  • Cepeda MS. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol. 2003;158(3):280–287. doi:10.1093/aje/kwg115.
  • Egbe AC. Birth defects in the newborn population: race and ethnicity. Pediatr Neonatol. 2015;56(3):183–188. doi:10.1016/j.pedneo.2014.10.002.
  • Brent RL, Beckman DA. Environmental teratogens. Bull N Acad Med. 1990;66(2):123–163.
  • Sakata S, Konishi S, Ng CFS, Watanabe C. Preterm birth rates in Japan from 1979 to 2014: analysis of national vital statistics: preterm birth rates in Japan. J Obstet Gynaecol Res. 2018;44(3):390–396. doi:10.1111/jog.13460.
  • Takemoto Y, Ota E, Yoneoka D, Mori R, Takeda S. Japanese secular trends in birthweight and the prevalence of low birthweight infants during the last three decades: a population-based study. Sci Rep. 2016;6(1):31396. doi:10.1038/srep31396.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.